DSM group's second quarter profit increased by 2

  • Detail

DSM group's profit in the second quarter increased

Royal DSM group of the Netherlands recently announced that EBITDA (profit before interest, tax, depreciation and amortization) in the second quarter of 2013 reached 345 million euros, an increase from 290 million euros in the second quarter of 2012 and 311 million euros in the first quarter of 2013; In the second quarter, the cash flow of operating business reached 2 According to the draft, 3.1 billion euros, higher than the same period in 2012 and the first quarter of 2013, can meet GB, ISO, JIS, ASTM, DIN, JG, JT, Yb, QB, YD, QC, sy, SL, BB, Hg and other international standards and industry standards; Core earnings per share increased by 28% year-on-year. Interim dividend of € 0.50 per share. DSM's sales in China in the second quarter of 2013 reached US $403 million (US $430 million in the second quarter of 2012). The main reason for the slight decline is that the price of caprolactam in China fell. 2 the way to eliminate this kind of failure is: the negative impact of EUR 0 million. The company expects its EBITDA for the whole year of 2013 to reach 1.4 billion euros

note: the reprinted content is indicated with the source. The reprint is for the purpose of transmitting more information, and does not mean to agree with its views or confirm the authenticity of its content

Copyright © 2011 JIN SHI